This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · 2 days ago
Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More247 Wallst · 2 days ago
Guardant Health, Inc. (NASDAQ:GH) Stock Has Average Price Target of $190.00Defense World · 3 days ago
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026Business Wire · 5 days ago
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are WinningMarketBeat · 6 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarZacks Investment Research · Oct 15, 2026Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-genomic liquid biopsy dataset derived from advanced cancer patients.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 30, 2026 | -$0.76 | -$0.90 | Miss |
| May 7, 2026 | -$0.81 | -$0.85 | Miss |
| Feb 19, 2026 | -$0.77 | -$1.00 | Miss |
| Oct 29, 2025 | -$0.79 | -$0.74 | Beat |
| Jul 30, 2025 | -$0.74 | -$0.80 | Miss |
| Apr 30, 2025 | -$0.78 | -$0.77 | Beat |